§ 40.199 What problems always cause a drug test to be cancelled?
Wording effective January 1, 2018, superseded May 2, 2023.
(a) As the MRO, when the laboratory discovers a “fatal flaw” during its processing of incoming specimens (see § 40.83), the laboratory will report to you that the specimen has been “Rejected for Testing” (with the reason stated). You must always cancel such a test.
(b) The following are “fatal flaws”:
(1) There is no CCF;
(2) In cases where a specimen has been collected, there is no specimen submitted with the CCF;
(3) There is no printed collector's name and no collector's signature;
(4) Two separate collections are performed using one CCF;
(5) The specimen ID numbers on the specimen bottle and the CCF do not match;
(6) The specimen bottle seal is broken or shows evidence of tampering (and a split specimen cannot be re-designated, see § 40.83(h)); or
(7) Because of leakage or other causes, there is an insufficient amount of urine in the primary specimen bottle for analysis and the specimens cannot be re-designated (see § 40.83(h)).
(c) You must report the result as provided in § 40.161.
[65 FR 79526, Dec. 19, 2000, as amended at 82 FR 52245, Nov. 13, 2017]
Amendment history
5 distinct wordings on file since Oct. 1, 2001- [65 FR 79526, Dec. 19, 2000, as amended at 82 FR 52245, Nov. 13, 2017; 88 FR 27648, May 2, 2023]
- [65 FR 79526, Dec. 19, 2000, as amended at 82 FR 52245, Nov. 13, 2017]
- [65 FR 79526, Dec. 19, 2000, as amended at 82 FR 52245, Nov. 13, 2017]
- Oct. 1, 2001 → Nov. 13, 2017annual editions 2001–2016
A new entry appears whenever the regulatory words change between government snapshots. Day-precise from the eCFR (2017 onward); before that, one snapshot per annual CFR edition (revised as of October 1). Bracketed citations are the Federal Register history printed with the section.